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Abstract
The aim of this study was to demonstrate the potential application of electrically-assisted methods, including iontophoresis and
electroporation, on the transdermal delivery of buspirone hydrochloride from a submicron emulsion-based system. The results showed
that by applied iontophoresis at 0.5 mA/cm 2 for 3 h or electroporation at 1 pulse, 300 V, 200 ms, 0.5 min spacing for 10 min, increased
the cumulative amount of buspirone at 10 h by 2.4 and 2.1 folds, respectively, compared to passive diffusion. The combination of
iontophoresis and electroporation did not show synergistic effects. For long-time application of iontophoresis, the enhancement effect
decreased in the later stage due to skin polarization. The duty cycle of current applied was found to increase iontophoretic efficiency.
When compared to passive diffusion, the lag time of buspirone-loaded submicron emulsion permeated through skin was shortened from
3 h to 0.5 h with the use of both electrically-assisted methods, indicating that more rapid onset of buspirone could be obtained by using
electrically-assisted methods.
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Introduction
Buspirone hydrochloride is an orally administered
anxiolytic drug from the azapirone family of molecules. It
is as potent as the benzodiazepines, but does not produce the
sedation or motor impairment effect. The usual oral dosage
of buspirone is 5 to 20 mg, 3 times/day. The drug is rapidly
absorbed after administration, but it undergoes extensive
first-pass metabolism. It has a half-life of about 2 to 3 h and a
low absolute bioavailability of approximately 4%(1-3). Hence,
a transdermal system would provide an alternative way to
bypass the disadvantages of the oral route.
However, the most difficult aspect of a transdermal
delivery system is to overcome the barrier of stratum
corneum against foreign substances. The methods for
improving drug permeation through the skin include
use drug carriers as vehicle (such as liposome, polymeric
nanoparticles and microemulsion), penetration enhancers
and physical methods such as microneedle technologies,
electrically-assisted methods (iontophoresis and electroporation) and ultrasound(4-14). In order to obtain a synergistic enhancement effect with minimum skin damage and
irritation, various combinations of enhancement methods
* Author for correspondence. Tel: +886-7-3121101 ext. 2166;
Fax: +886-7-3210683; E-mail: pachwu@kmu.edu.tw

have been tested, including combinations of more than two
physical methods, more than two chemical enhancers with
different enhancing mechanisms, an electrically-assisted
method with chemical enhancers, and electrically-assisted
methods with a well-designed drug carrier, and some of them
have indeed resulted in improved skin permeation(8,14-20).
Our previous study(21) showed that the use of a submicron emulsion as a drug carrier could significantly enhance
the transdermal effect as compared with the control aqueous
group. Unfortunately, the lag time of the buspirone-loaded
submicron emulsion permeated through skin was still long
(about 3 h). Electrically-assisted methods such as electroporation and iontophoresis have been proven to modify the
structure of skin and facilitate drug transportation, particularly for ionic and macromolecular drugs such as peptides and
proteins(15,22,23). The electrically-assisted methods were used
to shorten the lag time of buspirone-loaded submicron emulsion and further facilitate transdermal delivery in this study.

Materials and methods
I. Materials
Buspirone hydrochloride was obtained from Excella
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GmbH (Germany). Sorbitan monolaurate (Span 20, HLB =
8.6) was obtained from Tokyo Chemical Industry (Japan).
Polyoxyethylene sorbitan monooleate (Tween 80, HLB = 15)
was obtained from Showa Corporation (Japan). Isopropyl
myristate (IPM) was obtained from Merck Chemicals
(Germany). Ketoprofen was obtained from Sigma-Aldrich
(USA). All other chemicals and solvents were of analytical
reagent grade.
II. Preparation of Drug-Loaded Submicron Emulsions
A mixture surfactant of Span 20 and Tween 80 at a
ratio of 2 : 3 was mixed well. The oily and aqueous phases
were separately prepared. The oily phase consisted of 0.3 g
of IPM and 1.2 g of mixture surfactant, while the aqueous
phase consisted of 5.1 g of double-distilled water and 3.4 g of
ethanol. The aqueous phase was added to the oily phase, and
then shaken by vortex at room temperature. Clear and transparent microemulsions were obtained. Buspirone (0.1 g) was
dissolved in the final submicron emulsion formulations.
Ш. In Vitro Skin Permeation Study
The permeability of buspirone-loaded submicron emulsions was determined using a modified Franz glass diffusion
cell fitted with the abdominal skin of excised Sprague Dawley
rat. The skin was mounted on the receptor compartment with
the stratum corneum side facing upwards into the donor
compartment and the dermal side facing downwards into the
receptor compartment. The donor cell was filled with 1 mL
of drug-loaded submicron emulsions and occluded by parafilm. The receptor compartment was filled with 20 mL of 0.1
M phosphate buffer (pH 7.4) and its temperature was maintained at 37 ± 0.5°C by a thermostatic water pump during the
experiment. The effective diffusion area was 3.46 cm 2. Five
hundred micro-liters of receptor medium was withdrawn
at predetermined intervals and replaced immediately with
an equal volume of receptor solution to maintain a constant
volume. The sample withdrawn from the receptor compartment was then analyzed by high performance liquid chromatography (HPLC). Each data point represented the average
of three determinations. The animal experimental protocol
was reviewed and approved by the Institutional Animal Care
and Use Committee of Kaohsiung Medical University. The
committee confirmed that the animal experiment followed
the guidelines set forth by the Guide for Laboratory Fact
Lines and Care.
IV. Protocol of Electrically-Assisted Method
Iontophoresis is the application of a low-level electrical
current that facilitates the migration of drug molecules from
the transdermal delivery system through the skin membranes.
The enhancement effect of iontophoresis is proportional to
the current intensity applied and application period. A higher
current might damage the skin in the process of iontophoresis. A current intensity of 0.5 mA/cm 2 has been reported

in literature to be the maximum acceptable level concerning
minimal skin damage and irritation(22). Therefore, in this
study, the current density was set at 0.5 mA/cm 2 to evaluate
the enhancement effect of the iontophoresis method on the
buspirone-loaded submicron emulsion transdermal delivery.
A pair of platinum wires with a diameter of 0.5 mm and an
effective length of 1.5 cm was horizontally immersed in the
buffer as electrodes, with the anode on the donor site and the
cathode on the receptor site. The electrodes were positioned
3 cm apart. They were connected to a direct current power
supply (Yokogawa Electrical Co. Model 7651, Japan). The
current density was set at 0.5 mA/cm 2. Iontophoresis was
applied constantly for 3 h and 10 h.
Electroporation involves the application of high voltage
(typically > 100 voltage) and short-duration (μs - ms) pulse
to create a new pathways within the membrane bilayers for
increasing the permeability. In general, increase the used
voltage and application time can increase the enhancement effect of drug transportation and skin damage(13,14).
According to previous study(14), the electroporation protocol
was set at 1 pulse (300 V, 200 ms) per 30 s, for 10 min. Voltages were expressed as applied values, instead of transdermal
values. The Electroporation (EP) was performed using an
exponential decay pulse generator (BTX Co., ECM 630
Electro Cell Manipulator, USA). A pair of platinum wires
(0.5 × 1.5 cm 2) was each located 3 cm away from the skin
in the diffusion cell. The anode was positioned on the donor
site, while the cathode was on the receptor site.
The duty cycle of iontophoresis was as follows: the
effect of pulse on/off interval on the iontophoretic flux of
buspirone-loaded submicron emulsion was studied at on/off
interval ratios varying from 1 : 1, 1 : 2, 2 : 1 and 2 : 2 under
a current density of 0.5 mA/cm 2.
The drug transportation of buspirone-loaded submicron
emulsions after EP and ITP applied for 10 h were complete
at 100.27 ± 2.53% and 97.57 ± 1.22%, respectively, also indicating that the formulation was stable.
V. HPLC Analysis
HPLC analysis was carried out using a Hitachi L-7100
series HPLC system. A Merck Lichrocart® C18 column
(250 × 4.6 mm i.d., particle size 5 mm) was used(4). The
mobile phase was a mixture of 0.01 M ammonium acetate
containing 1% triethylamine (adjusted to pH 4 by phosphoric
acid) and acetonitrile in the ratio of 50 : 50, at a flow rate of
1.5 mL/min. The UV detection wavelength was set at 245
nm. Ketoprofen (100 µg/mL) was used as internal standard.
The limit of quantitation was 5 µg/mL.
VI. Data Analysis
The cumulative amount of drug permeation through rat
skin was plotted as a function of time. The flux calculated
from the linear portion of the plot of cumulative amount
versus time (R2 > 0.9) was analyzed. Lag time was defined as
the first instance of drug detection. Penetration index (PI) of
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Table 1. Permeation parameters of buspirone-loaded submicron emulsion with and without electrically-assisted methods
Lag time (h)

Q3h (µg/cm2)

PI Q3h

Q10h (µg/cm2)

PI Q10h

Passive diffusion

3.0

50.9 ± 17.6

1.0

413.7 ± 74.5

1.0

ITP for 3 h

0.5

658.2 ± 323.0

12.9

1007.8 ± 492.3

2.4

EP for 10 min

0.5

321.0 ± 36.5

6.3

863.5 ± 38.5

2.1

EP + ITP

0.5

500.3 ± 136.9

9.8

917.2 ± 60.6

2.2

ITP: Iontophoresis at 0.5 mA/cm 2 for 3 h.
EP : Electrophoresis at 1 pulse, 300 V, 200 ms, 0.5 min spacing for 10 min.
EP + ITP: Electrophoresis at 1 pulse, 300 V, 200 ms, 0.5 min spacing for 10 min, and then iontophoresis at 0.5 mA/cm 2 for 3 h.
Q3h : Cumulative amount at 3 h.
Q10h : Cumulative amount at 10 h.
PI (Penetration Index): Cumulative amount of electrically-assisted method/Cumulative amount of passive diffusion.
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Figure 1. Cumulative amounts of buspirone permeation through rat
skin under varying electrically-assisted methods, namely iontophoresis (ITP) at 0.5 mA/cm 2 for 3 h, electroporation (EP) at 1 pulse, 300
V, 200 ms and 0.5 min spacing for 10 min, and combined iontophoresis and electroporation.

the electrically-assisted method was defined as the cumulative amount of passive control.

Results and discussion
The plots of cumulative amount versus time for buspirone penetration with and without applying electric current
are shown in Figure 1. It can be seen that buspirone penetration was markedly improved by the iontophoresis method,
particularly in the first 3 h (during the electric current
applying period). The cumulative amounts of buspirone
through rat skin by iontophoresis at 3 h and 10 h were 658.2
± 323.0 and 1007.8 ± 492.3 µg/cm2 respectively, a 12.9- and
2.4-fold increase as compared with passive diffusion (Table
1), indicating that the contribution of electrophoretic drift
enhanced by iontophoresis was significant for buspirone.
The possible enhancement mechanisms are (1) electrorepulsion, which is the repulsive force between the applied
electric current and entities of the same polarity, (2) increase

in skin permeability due to the decrease in skin resistance,
and (3) electroosmosis, which is the convective movement
of a solvent through a charged “pore” in response to the
preferential passage of counter-ions when an electric field
is applied(6,7,12). Furthermore, from Figure 1, it was found
that when the current density was switched off after 3 h, the
buspirone molecules could continue to permeate across the
skin. One explanation is the existence of a drug reservoir
within the skin. In the current-off period, the permeating ions
continued their release from the skin until the drug reservoir
drained off (24). Another explanation is the alternation of
the natural skin. The major route of iontophoretic transport
is believed to involve appendageal pores, including sweat
ducts and hair follicles. A non-appendageal pore pathway
has also been proposed, which probably implies the current
flow through “artificial shunts” because of disruption of the
organized structure of the stratum corneum(14,18).
Electroporation is the application of high intensity
electric field pulses to lipid bilayers of the stratum corneum,
followed by the creation of transient aqueous pathways within
the membrane bilayers for molecular transport(16,25,26). As
shown in Figure 1 and Table 1, the permeation of buspirone
was markedly improved by a 6.3- and 2.1-fold enhancement
in cumulative amounts at 3 h and 10 h respectively, relative to
the control. It was also found that the penetration rate in the
earlier stage (first 6 h) was higher than that in the later stage
(6 - 10 h), which indicates that alternation of skin structure
by electroporation can be maintained for a period of time
and is reversible. The continuous accumulation of buspirone
post-electroporation might indicate the formation of a drug
reservoir or alternation of skin structure(18,26).
In addition, electroporation is usually coupled with
iontophoresis to allow transdermal drug delivery to be further
facilitated(6,17). Hence the effect of the combination of electroporation and iontophoresis on drug permeation was also
evaluated in this study. Surprisingly, no synergistic effect
was observed (Figure 1). However, the result showed that
the iontophoresis method was more efficient than that of the
electroporation method for transporting buspirone through
skin. The lag time of the permeation of buspirone-loaded
submicron emulsion through skin was shortened from 3 h to
0.5 h by using both electrically-assisted methods, compared
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Conclusions
The application of electrically-assisted methods could
greatly enhance the transdermal permeation of buspirone
and shorten the lag time. Iontophoresis at 0.5 mA/cm 2 for 3 h
was more efficient than electroporation at 1 pulse, 300 V,
200 ms, 0.5 min spacing for 10 min for the transportation
of buspirone through skin. In the iontophoresis method, a
suitable on/off interval ratio of the current should be selected
to enhance iontophoretic efficiency.
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